Virtual ACC 2020 | Conscious Sedation in TAVR

According to the TVT Registry, patients who undergo transcatheter aortic valve replacement (TAVR) with conscious sedation have better outcomes, including lower mortality rates. A minimalist strategy always (sooner or later) proves to be superior across our whole range of procedures, from a simple diagnostic study with local anesthesia and a 4-Fr transradial access, to a transcatheter aortic valve replacement with percutaneous closure and conscious sedation.

This strategy is growing in the US, but in Europe it was adopted a while back.

Among interventional cardiologists, its adoption is as diverse as its definitions. However, pretty much everybody agrees on the use of transthoracic echocardiography and light sedation as a minimalist approach, as opposed to general anesthesia with an invasive management of the airway.

Only one trial to date, SOLVE-TAVI, randomized patients to one of the aforementioned strategies or the other, and it proved the noninferiority of a minimalist strategy. Such study, however, was underpowered to detect other events.


Read also: The Perks of Conscious Sedation in TAVR.


The analysis herein outlined was meant to be presented at the American College of Cardiology 2020 Scientific Session and simultaneously published in JACC: Cardiovascular Interventions. However, given the current worldwide pandemic, the event is unlikely to take place; in consequence, we can access this work digitally.

This study included 120,080 patients from over 500 sites, who underwent TAVR between 2016 and 2019. Globally, the proportion of patients managed through a minimalist strategy increased from 33% to 63%. Variation across sites was significant; one fourth of hospitals used conscious sedation in over 80% of procedures, and up to 13% of sites used general anesthesia in absolutely all cases.

Conscious sedation was associated with modestly lower in-hospital mortality (1.1% vs. 1.3% with general anesthesia; p = 0.01) and 30-day mortality (2.0% vs. 2.5%; p < 0.001).


Read also: TAVR in Extremely Large Annuli: Different Patients Might Need Different Prostheses.


The percentage of patients discharged home (88.9% vs. 86.1%; p < 0.001) and hospital length of stay (3.5 vs. 4.3 days; p < 0.001) were also significantly better with a minimalist approach.

Original Title: Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: variation in practice and outcomes.

Reference: Butala NM et al. J Am Coll Cardiovasc Intv. 2020; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...